Medexus Pharmaceuticals holds annual shareholder meeting
Bitget2026/09/24 21:31- Medexus Pharmaceuticals held its virtual annual shareholder meeting on Sept. 24, 2026.
- Shareholders backed the appointment of PricewaterhouseCoopers LLP as auditor.
- Votes also adopted amendments to the equity incentive compensation plan.
- Director nominees listed in the Aug. 10, 2026 circular were elected to serve until the next annual meeting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Grayscale Warns Bitcoin’s Lower Volatility Doesn’t Mean Lower Risk

CoreWeave downplays Jensen Huang's departure, says Nvidia remains a key partner
CoreWeave’s Vice President of Strategy stated that the company will continue its partnership with Nvidia, with hundreds or even thousands of layers of business collaboration between the two sides. Nvidia is a vast institution, not reliant on a single individual for its operations. However, this statement failed to boost market sentiment, and CoreWeave’s stock is currently down more than 5% during intraday trading.

